Will creatine cause weight gain in women?

Creatine draws water into muscle cells, which can add 1 to 2 kg of body weight initially, primarily as intracellular fluid, not fat. This stabilizes over time. Creatine alone does not build muscle mass without resistance training. The weight change reflects improved cellular hydration in muscle tissue.

What creatine dose is recommended for women?

Creatine monohydrate at 3 to 5 grams per day is the standard maintenance dose. A loading phase of 20 g/day for 5 to 7 days is optional and not necessary for brain health applications. Monohydrate is the most studied and cost-effective form. Consistent daily intake matters more than timing.

Is creatine useful for women who don't exercise?

Yes, particularly for brain energy metabolism. Creatine supports ATP availability in the brain during periods of cognitive demand, sleep deprivation, or stress. Studies show cognitive performance benefits from creatine supplementation even without exercise. Women who eat plant-based diets may have lower baseline creatine levels and see more pronounced cognitive benefits.

Creatine for Women: The Science Beyond the Gym for Brain and Muscle

Creatine has a gym problem. Decades of marketing to male athletes built an association between creatine and bulk, performance, and lifting. That association is accurate but incomplete. Creatine is a brain substrate before it is a muscle one. And for women specifically, the biological argument for supplementation extends well beyond exercise.

The Baseline Gap Between Men and Women

Creatine is synthesized in the liver and kidneys from arginine, glycine, and methionine. It is also obtained from meat and fish. Plant-based foods contain essentially none.

Muscle mass determines creatine storage capacity. Because women generally have less muscle mass than men, their total creatine stores are proportionally lower. A 2025 narrative review published in Nutrients quantified this: women have 70 to 80 percent lower intramuscular creatine stores than men.

The more clinically significant detail is the brain. Women have lower creatine concentrations in the prefrontal cortex, the region governing mood regulation, attention, working memory, and executive function. A lower baseline means the relative improvement from supplementation is larger, which partially explains why women tend to show greater cognitive benefit from creatine than men in research.

What Creatine Does in the Brain

The brain accounts for about 2 percent of body weight but consumes roughly 20 percent of resting energy. ATP demand is high and variable. Creatine is stored as phosphocreatine (PCr) in the brain and serves as an immediate buffer, regenerating ATP when demand spikes.

Sleep deprivation, psychological stress, and prolonged cognitive work all increase brain creatine demand. Multiple studies have shown that creatine supplementation improves performance on cognitive tasks under sleep deprivation, reduces mental fatigue, and maintains processing speed in conditions where baseline creatine is insufficient.

A large meta-analysis found that creatine supplementation produced significant improvements in short-term memory and reasoning ability. The effect was more pronounced in women and in older adults, both groups with lower baseline stores.

The relationship between creatine and mood is also being investigated. Several clinical trials have found that creatine augments the efficacy of SSRI antidepressants. The hypothesis is that brain energy metabolism is a substrate for mood regulation, and creatine supports that substrate.

Menstrual Cycle and Creatine Needs

There is emerging evidence that creatine needs vary across the menstrual cycle. During the luteal phase (the two weeks between ovulation and menstruation), shifts in estrogen and progesterone affect energy metabolism and mood. Some preliminary data suggest creatine supplementation during this phase may help buffer energy dips and mood changes.

Research into creatine and premenstrual syndrome (PMS) is early, but the mechanistic rationale connects: frontal cortex energy supply, mood regulation, and the hormonal fluctuations that characterize the luteal phase overlap in ways that creatine’s brain energy buffering could address.

Perimenopause and Beyond

The case for creatine strengthens further around the perimenopausal transition. Estrogen supports muscle protein synthesis, and its decline in perimenopause and menopause accelerates muscle loss (sarcopenia). Creatine combined with resistance training is one of the more evidence-backed strategies for attenuating this loss.

Bone density is also implicated. Creatine interacts with IGF-1 signaling pathways involved in bone metabolism, and preliminary evidence suggests it may help slow bone density decline in postmenopausal women when combined with exercise.

Market Growth and Demographic Shift

The global creatine market grew from $484 million in 2024 to $545.6 million in 2025. The expansion reflects a shift in who the product is being marketed to: women, older adults, cognitive health seekers, and vegans, all populations where baseline creatine is lower and benefit-to-cost ratios are potentially higher.

The framing has changed. Creatine is no longer just about how much weight you can lift. For women navigating cognitive demands, hormonal transitions, and long-term muscle and bone health, it is increasingly a foundational consideration, not an athletic supplement.

Source: UCLA Health / PMC